Jepsy Grace Yango wa yango

Dr. Jepsy Grace Yango wa yango

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
LPLaurene Peckeu-Abboud
Laurene Peckeu-Abboud
PMPatrick Mangoni
Patrick Mangoni
KCKaouther Chammam
Kaouther Chammam
PKPapy Kwete
Papy Kwete
PLPatrick Mutombo Lupola
Patrick Mutombo Lupola
PMPlacide Mbala
Placide Mbala
We performed a cross-sectional survey on vaccination-related knowledge, attitudes, and practices (KAP) among randomly selected parents of <5 years-old children, elderly populations (aged ≥ 55 years), and health care workers (HCWs) in 10 health zones from 4 provinces of the Democratic Republic of Congo (DRC). Questionnaires targeted both routine (BCG, measles, polio) and outbreak-related (cholera, Ebola, COVID-19) vaccinations. In total, 2751 participants were included, 1165 parents, 1040 elderly, and 546 HCWs. In general, KAP expressed were supportive of vaccination uptake, although concerns regarding side effects and feelings of being insufficiently informed were more prevalent among parents and the elderly. Vaccine acceptance was lower for outbreak vaccinations (57%) than for routine vaccinations (90%). HCWs expressed the highest vaccine acceptance. Problems with the vaccine supply chain were reported by 20% of respondents. Despite a high level of positive KAP towards vaccination, parents and the elderly expressed a need to be better informed and had concerns regarding vaccine side-effects. A high acceptance for routine vaccinations was reported by participants, but somewhat less for outbreak vaccinations. In conclusion, HCWs in the communities could play a key role in the increased uptake of routine vaccinations and in optimizing uptake during outbreaks, provided that the supply chain is functioning well.

26 August 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
JYJepsy Grace Yango wa yango
Jepsy Grace Yango wa yango
ATAntoine Oloma Tshomba
Antoine Oloma Tshomba
PKPapy Kwete
Papy Kwete
JMJoule Madinga
Joule Madinga
SMSabue Mulangu
Sabue Mulangu
BJBart K. M. Jacobs
Bart K. M. Jacobs
The 2018–2020 Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC) was the largest since the disease‘s discovery in 1976. Rapid identification and isolation of EVD patients are crucial during triage. This study aimed to develop a clinical prediction score for EVD using clinical and epidemiological predictors. We conducted a retrospective cross-sectional study using surveillance data from EVD outbreak, collected during routine clinical care at the Ebola Transit Center (ETC) in Beni, DRC, from 2018 to 2020. The Spiegelhalter and Knill-Jones method was used for score development, including potential predictors with an adjusted likelihood ratio above 2 or below 0.50. Validation was performed using a dataset previously published in PLOSOne by Tshomba et al. Among 3725 patients screened, 3698 fulfilled the inclusion criteria, with 571 (15.4%) testing positive for EVD via RT-PCR Test. Seven predictive factors were identified: asthenia, sore throat, conjunctivitis, bleeding gums, hematemesis, contact with a sick person, and contact with a traditional healer. The prediction score achieved an Area under the receiver operating characteristic (AUROC) of 0.764, with 81.4% sensitivity and 53.6% specificity at a -1 cutoff. External validation demonstrated an AUROC of 0.766, with 80.8% sensitivity and 41.4% specificity at the -1 cutoff. Our study developed a screening tool to assess the risk of suspected patients developing EVD and being admitted to ETUs for RT-PCR testing and treatment. External validation results affirmed the model’s reliability and generalizability in similar settings, suggesting its potential integration into clinical practice. Given the severity and urgency of EVD as well as the risk nosocomial EVD transmission, it is essential to continuously update these models with real-time data on symptoms, disease progression, patient outcomes and validated RDT during EVD outbreaks. This approach will enhance model accuracy, enabling more precise risk assessments and more effective outbreak management.

11 July 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
LOLeader Lawanga Ontshick
Leader Lawanga Ontshick
JYJepsy Grace Yango wa yango
Jepsy Grace Yango wa yango
AYAnge Mubiala Yaya
Ange Mubiala Yaya
OMOlivier Tshiani Mbaya
Olivier Tshiani Mbaya
JTJoule Madinga Twan
Joule Madinga Twan
RMRostin Mabela Makengo Matendo
Rostin Mabela Makengo Matendo
Ebola Virus Disease (EVD) remains a significant public health threat, particularly in sub-Saharan Africa. During the 10th Ebola outbreak in the Democratic Republic of Congo (DRC), the Pamoja Tulinde Maisha clinical trial (PALM-RCT) provided a unique opportunity to evaluate new therapeutic interventions. Despite these advances, limited knowledge exists regarding the dynamic evolution of mortality risk factors in EVD patients. This study aimed to model risk factors associated with mortality using logistic regression on unbalanced panel data from patients enrolled in this trial.We conducted a retrospective secondary analysis of longitudinal data from 617 EVD patients included in the PALM-RCT. Data were collected at five time points: Day0 (admission), Day7, Day14, Day21, and Day28. A binary logistic regression model was applied at each time point to identify significant predictors of mortality. The Hosmer-Lemeshow test was used to assess model calibration and internal validation. At Day0 (admission), six significant predictors of mortality were identified: viral load (RT-PCR cycle threshold value), creatinine, alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), haemorrhage, shortness of breath, and conjunctivitis. By Day7, five predictors emerged: sodium, ASAT, coma, abdominal pain, and shortness of breath. At Day14, two predictors remained significant: ASAT and mental state changes. No significant predictors were identified at Day21 and Day28. The dynamic nature of these risk factors highlights the importance of continuous monitoring throughout the clinical course of EVD.Our study demonstrates that mortality risk factors in EVD patients evolve over time, suggesting that a dynamic approach to patient monitoring is critical. Early risk factors such as viral load and renal function should guide initial interventions, while neurological symptoms and electrolyte imbalances require attention in later stages. These findings support a personalized approach to EVD management, where clinical care is adjusted based on real-time clinical data to improve patient outcomes.

27 September 2026 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
SMSabue Mulangu
Sabue Mulangu
JYJepsy Grace Yango wa yango
Jepsy Grace Yango wa yango
FLFelicia Lipansky
Felicia Lipansky
GMGael Mukendi
Gael Mukendi
DKDonatien Kazadi
Donatien Kazadi
JMJean Jacques Muyembe
Jean Jacques Muyembe